Safety and efficacy of duloxetine treatment in older and younger patients with osteoarthritis knee pain: a post hoc, subgroup analysis of two randomized, placebo-controlled trials

por Micca, Joseph L, Ruff, Dustin, Ahl, Jonna, Wohlreich, Madelaine M
Publicado 2013

100% Response Rate to Galcanezumab in Patients With Episodic Migraine: A Post Hoc Analysis of the Results From Phase 3, Randomized, Double‐Blind, Placebo‐Controlled EVOLVE‐1 and EV...

por Rosen, Noah, Pearlman, Eric, Ruff, Dustin, Day, Kathleen, Jim Nagy, Abraham
Publicado 2018

Response to Misused and Misleading: 100% Response Rate to Galcanezumab in Patients With Episodic Migraine

por Rosen, Noah, Pearlman, Eric, Ruff, Dustin, Day, Kathleen, Nagy, Abraham Jim
Publicado 2019

Analysis of Initial Nonresponders to Galcanezumab in Patients With Episodic or Chronic Migraine: Results From the EVOLVE‐1, EVOLVE‐2, and REGAIN Randomized, Double‐Blind, Placebo‐C...

por Nichols, Russell, Doty, Erin, Sacco, Sara, Ruff, Dustin, Pearlman, Eric, Aurora, Sheena K.
Publicado 2018

A pilot study for augmenting atomoxetine with methylphenidate: safety of concomitant therapy in children with attention-deficit/hyperactivity disorder

por Carlson, Gabrielle A, Dunn, David, Kelsey, Douglas, Ruff, Dustin, Ball, Susan, Ahrbecker, Lisa, Allen, Albert J
Publicado 2007

Patient satisfaction, health care resource utilization, and acute headache medication use with galcanezumab: results from a 12-month open-label study in patients with migraine

por Ford, Janet H, Foster, Shonda A, Stauffer, Virginia L, Ruff, Dustin D, Aurora, Sheena K, Versijpt, Jan
Publicado 2018

Trajectory of migraine-related disability following long-term treatment with lasmiditan: results of the GLADIATOR study

por Lipton, Richard B., Lombard, Louise, Ruff, Dustin D., Krege, John H., Loo, Li Shen, Buchanan, Andrew, Melby, Thomas E., Buse, Dawn C.
Publicado 2020

Migraine Headache Day Response Rates and the Implications to Patient Functioning: An Evaluation of 3 Randomized Phase 3 Clinical Trials of Galcanezumab in Patients With Migraine

por Ford, Janet H., Kurth, Tobias, Starling, Amaal J., Ayer, David W., Wietecha, Linda A., Port, Martha D., Rettiganti, Mallikarjuna, Ruff, Dustin D.
Publicado 2020